Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Positron emission tomography industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends (USD Million & Units)
2.1.2 Product type trends (USD Million & Units)
2.1.3 Detector type trends (USD Million & Units)
2.1.4 End-use trends (USD Million & Units)
2.1.5 Regional trends (USD Million & Units)
Chapter 3 Positron Emission Tomography Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Integration of X-ray computed tomography (CT) into PET
3.2.1.2 Technological advancements in positron emission tomography
3.2.1.3 Rising demand for PET analysis in radio pharmaceuticals
3.2.1.4 Increasing shift towards image-guided interventions
3.2.2 Industry pitfalls & challenges
3.2.2.1 Diminished life span of radioisotopes
3.2.2.2 Stringent regulatory approvals
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By detector type
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Technology landscape
3.6 Value chain analysis
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Koninklijke Philips NV
4.1.2 GE Healthcare
4.1.3 Siemens Healthineers AG
4.2 Competitive dashboard, 2021
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 Positron Emission Tomography Market, By Product Type
5.1 Key product trends
5.2 Partial ring PET scanner
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3 Full ring PET scanner
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 6 Positron Emission Tomography Market, By Detector Type
6.1 Key product trends
6.2 Lutetium oxyorthosilicate (LSO)
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Market estimates and forecast, 2018 - 2032 (Units)
6.3 Silicon photomultiplier (SiPM)
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Market estimates and forecast, 2018 - 2032 (Units)
6.4 Lutetium yttrium orthosilicate (LYSO)
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.2 Market estimates and forecast, 2018 - 2032 (Units)
6.5 Silicon photomultiplier (SiPM)
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 7 Positron Emission Tomography Market, By End-use
7.1 Key end-use trends
7.2 Hospitals
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.2.2 Market estimates and forecast, 2018 - 2032 (Units)
7.3 Diagnostic centers
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3.2 Market estimates and forecast, 2018 - 2032 (Units)
7.4 Ambulatory surgical centers
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4.2 Market estimates and forecast, 2018 - 2032 (Units)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 8 Positron Emission Tomography Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Poland
8.3.7 Switzerland
8.3.8 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Turkey
8.6.5 Egypt
8.6.6 Israel
8.6.7 Qatar
Chapter 9 Company Profiles
9.1 Siemens Healthineers AG
9.2 General Electric Company (GE Healthcare)
9.3 Koninklijke Philips N.V
9.4 Neusoft Corporation
9.5 Yangzhou Kindsway Biotech Co. Ltd
9.6 CMR Naviscan
9.7 Mediso Ltd
9.8 Fujifilm Holdings Corporation
9.9 CANON MEDICAL SYSTEMS CORPORATION
9.10 Radialis Inc.
9.11 Toshiba Medical Systems Corporation
